Alexander Klimka

511 total citations
16 papers, 413 citations indexed

About

Alexander Klimka is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Alexander Klimka has authored 16 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Alexander Klimka's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Alexander Klimka is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Alexander Klimka collaborates with scholars based in Germany, Netherlands and Iran. Alexander Klimka's co-authors include Stefan Barth, Andreas Engert, B. Matthey, Michael Hühn, E. A. Galinski, Volker Diehl, Hennie R. Hoogenboom, J. W. Arends, Rob C. Roovers and Martin Krönke and has published in prestigious journals such as Applied and Environmental Microbiology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Alexander Klimka

16 papers receiving 391 citations

Peers

Countries citing papers authored by Alexander Klimka

Since Specialization

Citations

This map shows the geographic impact of Alexander Klimka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Klimka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Klimka more than expected).

Fields of papers citing papers by Alexander Klimka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Klimka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Klimka. The network helps show where Alexander Klimka may publish in the future.

Co-authorship network of co-authors of Alexander Klimka

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Klimka. A scholar is included among the top collaborators of Alexander Klimka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Klimka. Alexander Klimka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Development of an immunochromatographic lateral flow assay to rapidly detect OXA-23-, OXA-40-, OXA-58- and NDM-mediated carbapenem resistance determinants in Acinetobacter baumannii 2023 ·Journal of Medical Microbiology ·Sonja Mertins, Paul G. Higgins, (unknown), (unknown), (unknown), Pascal Mertens, (unknown), (unknown), Harald Seifert, Martin Krönke, Alexander Klimka	5
2	Epitope-specific immunity against Staphylococcus aureus coproporphyrinogen III oxidase 2021 ·npj Vaccines ·Alexander Klimka, Sonja Mertins, (unknown), (unknown), Paul G. Higgins, Saskia Diana Günther, (unknown), Oleg Krut, Martin Krönke	19
3	Generation and selection of antibodies for a novel immunochromatographic lateral flow test to rapidly identify OXA-23-like-mediated carbapenem resistance in Acinetobacter baumannii 2019 ·Journal of Medical Microbiology ·Sonja Mertins, Paul G. Higgins, (unknown), Céline Borlon, (unknown), Pascal Mertens, Harald Seifert, Martin Krönke, Alexander Klimka	6
4	Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: anin vivostudy 2015 ·Immunopharmacology and Immunotoxicology ·(unknown), (unknown), Alexander Klimka, (unknown), Mohsen Navari, Mohammad Javad Rasaee	22
5	Montanide ISA 71 VG is Advantageous to Freund's Adjuvant in Immunization Against S. aureus Infection of Mice 2015 ·Scandinavian Journal of Immunology ·Alexander Klimka, Luana Roberta Michels, (unknown), (unknown), Martin Krönke, Oleg Krut	21
6	Gene transfer of Hodgkin cell lines via multivalent anti-CD30 scFv displaying bacteriophage 2008 ·BMC Molecular Biology ·(unknown), (unknown), Martin Krönke, Alexander Klimka	4
7	Metalloproteinase inhibition augments antitumor efficacy of the anti‐CD30 immunotoxin Ki‐3(scFv)‐ETA′ against human lymphomas in vivo 2004 ·International Journal of Cancer ·(unknown), Peter Borchmann, Roland Schnell, Samir Tawadros, Hans Lange, Michael Hühn, Alexander Klimka, Mehmet Kemal Tur, Stefan Barth, Andreas Engert, Hinrich P. Hansen	16
8	Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines. 2004 ·International Journal of Molecular Medicine ·Achim Rothe, Alexander Klimka, Mehmet Kemal Tur, (unknown), Michael Hühn, Stephanie Sasse, Peter Mallmann, Andreas Engert, Stefan Barth	20
9	Measurement of antibody-membrane interactions by surface plasmon resonance. 2004 ·International Journal of Molecular Medicine ·Alexander Klimka, Mehmet Kemal Tur, Michael Hühn, Uwe Bierfreund, (unknown), Rainer Fischer, Ricarda Finnern, Stefan Barth	4
10	Construction of proteolysis resistant human interleukin-2 by fusion to its protective single chain antibody 2003 ·Cytokine ·Alexander Klimka, (unknown), (unknown)	6
11	A novel approach for immunization, screening and characterization of selected scFv libraries using membrane fractions of tumor cells 2003 ·International Journal of Molecular Medicine ·Mehmet Kemal Tur, Achim Rothe, Michael Hühn, (unknown), Alexander Klimka, Michael Stöcker, Andreas Engert, (unknown), (unknown), Stefan Barth	11
12	Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning 2000 ·British Journal of Cancer ·Alexander Klimka, B. Matthey, Rob C. Roovers, Stefan Barth, J. W. Arends, Andreas Engert, Hennie R. Hoogenboom	32
13	Compatible-Solute-Supported Periplasmic Expression of Functional Recombinant Proteins under Stress Conditions 2000 ·Applied and Environmental Microbiology ·Stefan Barth, Michael Hühn, B. Matthey, Alexander Klimka, E. A. Galinski, Andreas Engert	138
14	A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins 1999 ·Gene ·(unknown), Andreas Engert, Alexander Klimka, Volker Diehl, Stefan Barth	34
15	An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA’) is a potent immunotoxin against a Hodgkin-derived cell line 1999 ·British Journal of Cancer ·Alexander Klimka, Stefan Barth, B. Matthey, Rob C. Roovers, Hilmar Lemke, Hinrich P. Hansen, J. W. Arends, Volker Diehl, Hennie R. Hoogenboom, Andreas Engert	64
16	A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines. 1996 ·PubMed ·Alexander Klimka, Stefan Barth, (unknown), Winfried S. Wels, (unknown), Jean‐Christophe Renauld, Hans Tesch, Heribert Bohlen, Diehl, Andreas Engert	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact